Latest Breaking News On - Michael galfetti - Page 2 : comparemela.com

/PRNewswire/ Element Biosciences, Inc. developer of an innovative DNA sequencing platform that is disrupting the genomics industry today announced Avidity.

Kristi heimChris boothMatthew kellingerMichael galfettiPrnewswire element biosciences incDevelopment of the cloudbreakElement biosciences incFaster run timesMore applicationsAvidity cloudbreakElement vice presidentAvidity sequencingElement biosciences